Go offline with the Player FM app!
Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D.
Manage episode 474897474 series 2908385
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, invited Min-Han Tan, M.B.B.S., FRCP, Ph.D., founding CEO and medical director of Lucence, to discuss liquid biopsy cancer testing. Mayo Clinic Laboratories and Lucence recently announced a collaboration to expand access to this cutting-edge cancer test that is designed to detect clinically relevant biomarkers in ctDNA and ctRNA.
During their conversation, Dr. Morice and Dr. Tan explore:
- Inspiration for developing the liquid biopsy.
- Features that differentiate LiquidHALLMARK® from existing cancer tests.
- Patients who will benefit from the test and how an oncologist might use the results.
- The future potential of liquid biopsy advancements.
350 episodes
Manage episode 474897474 series 2908385
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, invited Min-Han Tan, M.B.B.S., FRCP, Ph.D., founding CEO and medical director of Lucence, to discuss liquid biopsy cancer testing. Mayo Clinic Laboratories and Lucence recently announced a collaboration to expand access to this cutting-edge cancer test that is designed to detect clinically relevant biomarkers in ctDNA and ctRNA.
During their conversation, Dr. Morice and Dr. Tan explore:
- Inspiration for developing the liquid biopsy.
- Features that differentiate LiquidHALLMARK® from existing cancer tests.
- Patients who will benefit from the test and how an oncologist might use the results.
- The future potential of liquid biopsy advancements.
350 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.